{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:36:08Z","timestamp":1759412168997},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T00:00:00Z","timestamp":1486944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Funds of Collaborative innovation center for major autoimmune disease","award":["CXNLX-1401"],"award-info":[{"award-number":["CXNLX-1401"]}]},{"name":"THe Chinese national high level personnel special support plan."},{"name":"CW gratefully acknowledges support from Biotechnology and Biological Sciences Research Council (BBSRC)","award":["(BB\/I025379\/1, BB\/P004695\/1"],"award-info":[{"award-number":["(BB\/I025379\/1, BB\/P004695\/1"]}]},{"name":"National Institute of Aging","award":["NIA, 1R01AG049321-01A1"],"award-info":[{"award-number":["NIA, 1R01AG049321-01A1"]}]},{"name":"The Royal Society and NSFC","award":["IE151259"],"award-info":[{"award-number":["IE151259"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0172108","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T19:48:21Z","timestamp":1487015301000},"page":"e0172108","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China"],"prefix":"10.1371","volume":"12","author":[{"given":"Fan-Ya","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Gang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin-Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,2,13]]},"reference":[{"issue":"1","key":"ref1","first-page":"21","article-title":"Hum Vaccin Immunother","volume":"11","author":"HY Naim","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"ref2","unstructured":"Nakia S. Clemmons, Paul A. Gastanaduy, Amy Parker Fiebelkorn, Susan B. Redd, Gregory S. Wallace. Measles\u2014United States, January 4\u2013April 2, 2015 [Morbidity and Mortality Weekly Report (MMWR)]. 2015. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6414a1.htm\" xlink:type=\"simple\">http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6414a1.htm<\/ext-link>."},{"issue":"9832","key":"ref3","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(12)60522-4","article-title":"Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data","volume":"379","author":"E Simons","year":"2012","journal-title":"The Lancet"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1093\/infdis\/jir081","article-title":"Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990\u20132008","volume":"204","author":"MM van den Ent","year":"2011","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1186\/1471-2458-13-986","article-title":"A 60-year review on the changing epidemiology of measles in capital Beijing, China, 1951\u20132011","volume":"13","author":"J Li","year":"2013","journal-title":"BMC Public Health"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3201\/eid2103.140646","article-title":"Endemic and imported measles virus-associated outbreaks among adults, Beijing, China, 2013","volume":"21","author":"M Chen","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"17","key":"ref7","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.vaccine.2015.02.078","article-title":"Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003\u20132009","volume":"33","author":"S Zuo","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4161\/hv.24032","article-title":"The epidemiological characteristics of measles and difficulties of measles elimination in Hang Zhou, China","volume":"9","author":"S Liu","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"46","key":"ref9","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1016\/j.vaccine.2015.10.008","article-title":"The epidemiology of measles in Tianjin, China, 2005\u20132014","volume":"33","author":"X Wang","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2471\/BLT.13.130195","article-title":"Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data","volume":"92","author":"C Ma","year":"2014","journal-title":"Bull World Health Organ"},{"key":"ref11","unstructured":"National Health and Family Planning Commission of the People&apos;s Republic of China. China Information System for Disease Control and Prevention. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/10.249.1.170\/\" xlink:type=\"simple\">http:\/\/10.249.1.170\/<\/ext-link>,."},{"key":"ref12","unstructured":"World Health Organization, Regional Office for the Western Pacific. Immunization safety surveillance: guidelines for immunization programme managers on surveillance of adverse events following immunization. 3rd ed.: Manila: WHO Regional Office for the Western Pacific 2015. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/iris.wpro.who.int\/handle\/10665.1\/12620\" xlink:type=\"simple\">http:\/\/iris.wpro.who.int\/handle\/10665.1\/12620<\/ext-link>."},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1542\/peds.2014-1822","article-title":"Safety of measles-containing vaccines in 1-year-old children","volume":"135","author":"NP Klein","year":"2015","journal-title":"Pediatrics"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.vaccine.2014.10.071","article-title":"Febrile seizures following measles and varicella vaccines in young children in Australia","volume":"33","author":"KK Macartney","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1542\/peds.2011-3198","article-title":"Measles-containing vaccines and febrile seizures in children age 4 to 6 years","volume":"129","author":"NP Klein","year":"2012","journal-title":"Pediatrics"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamapediatrics.2013.2745","article-title":"Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children","volume":"167","author":"A Rowhani-Rahbar","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"22","key":"ref17","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1016\/j.vaccine.2011.02.067","article-title":"Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses","volume":"29","author":"HC Rumke","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1008553","article-title":"Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China","volume":"364","author":"XF Liang","year":"2011","journal-title":"The New England journal of medicine"},{"key":"ref19","unstructured":"National Health and Family Planning Commission of the People&apos;s Republic of China, State Food and Drug Administration of China. National guideline for the surveillance of adverse events following immunization (AEFI). 2010. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.moh.gov.cn\/jkj\/s3581\/201402\/5dd5633d93174a7c8e93d8af7579a613.shtml\" xlink:type=\"simple\">http:\/\/www.moh.gov.cn\/jkj\/s3581\/201402\/5dd5633d93174a7c8e93d8af7579a613.shtml<\/ext-link>."},{"issue":"31","key":"ref20","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1016\/j.vaccine.2007.02.066","article-title":"Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"J Beigel","year":"2007","journal-title":"Vaccine"},{"issue":"31","key":"ref21","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1016\/j.vaccine.2007.02.065","article-title":"Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"JF Jones","year":"2007","journal-title":"Vaccine"},{"issue":"31","key":"ref22","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"JU Ruggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"31","key":"ref23","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"JJ Sejvar","year":"2007","journal-title":"Vaccine"},{"issue":"31","key":"ref24","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1016\/j.vaccine.2007.02.067","article-title":"Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"RP Wise","year":"2007","journal-title":"Vaccine"},{"issue":"5\u20136","key":"ref25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.vaccine.2003.09.008","article-title":"Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"J Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"issue":"5\u20136","key":"ref26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.vaccine.2003.09.007","article-title":"Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation","volume":"22","author":"S Michael Marcy","year":"2004","journal-title":"Vaccine"},{"issue":"52","key":"ref27","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1016\/j.vaccine.2008.10.006","article-title":"A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"26","author":"J Gidudu","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.vaccine.2010.11.065","article-title":"Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"J Gidudu","year":"2011","journal-title":"Vaccine"},{"key":"ref29","unstructured":"Shanghai Institute of Biological Products. Measles, Mumps and Rubella Combined Vaccine, Live,. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.siobp.com\/home\/ProductCenter\/PreventionProduct_2.aspx\" xlink:type=\"simple\">http:\/\/www.siobp.com\/home\/ProductCenter\/PreventionProduct_2.aspx<\/ext-link>."},{"key":"ref30","unstructured":"Shanghai Institute of Biological Products. Measles and Mumps Combined Vaccine, Live. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.siobp.com\/home\/ProductCenter\/PreventionProduct_4.aspx\" xlink:type=\"simple\">http:\/\/www.siobp.com\/home\/ProductCenter\/PreventionProduct_4.aspx<\/ext-link>."},{"key":"ref31","unstructured":"Shanghai Institute of Biological Products. Measles Vaccine, Live. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.siobp.com\/home\/ProductCenter\/PreventionProduct_9.aspx\" xlink:type=\"simple\">http:\/\/www.siobp.com\/home\/ProductCenter\/PreventionProduct_9.aspx<\/ext-link>."},{"key":"ref32","unstructured":"Beijing Tiantan of Biological Products. Measles and Rubella Combined Vaccine, Live. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.tiantanbio.com\/pin2.asp?dalei=1\" xlink:type=\"simple\">http:\/\/www.tiantanbio.com\/pin2.asp?dalei=1<\/ext-link>."},{"key":"ref33","first-page":"99","article-title":"Analysis on the surveillance of adverse events following immunization in China, 2009","volume":"2","author":"WD Wu","year":"2011","journal-title":"Chinese Journal of Vaccines and Immunization"},{"key":"ref34","first-page":"385","article-title":"Analysis on the surveillance of adverse events following immunization in China, 2010","volume":"5","author":"WD Wu","year":"2012","journal-title":"Chinese Journal of Vaccines and Immunization"},{"key":"ref35","first-page":"97","article-title":"Analysis on Surveillance Data of Adverse Events Following Immunization in China, 2011","volume":"2","author":"WD Wu","year":"2013","journal-title":"Chinese Journal of Vaccines and Immunization"},{"key":"ref36","article-title":"Analysis on Surveillance Data of Adverse Events Following Immunization in China, 2012","volume":"1","author":"WD Wu","year":"2014","journal-title":"Chinese Journal of Vaccines and Immunization"},{"key":"ref37","first-page":"121","article-title":"Evaluation of the Adverse Events Following Immunization Information Management System in China, 2013","volume":"2","author":"JK Ye","year":"2015","journal-title":"Chinese Journal of Vaccines and Immunization"},{"key":"ref38","first-page":"125","article-title":"Analysis of Surveillance for Adverse Events Following Immunization in China, 2014","volume":"2","author":"JK Ye","year":"2016","journal-title":"Chinese Journal of Vaccines and Immunization"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0172108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T08:43:55Z","timestamp":1589013835000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0172108"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,13]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0172108","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,13]]}}}